Vincent Hentz

Publication Details

  • Collagenase clostridium histolyticum for Dupuytren's contracture.

    Desai SS, Hentz VR. Expert Opin Biol Ther. 2010; 10 (9): 1395-404

    Dupuytren's disease is a non-malignant, progressive disorder of the hands that can severely limit hand function and diminish overall quality of life. With global life expectancy increasing, the prevalence of this disease appears to be increasing amongst all ethnic groups. Treatment has traditionally remained surgical with few effective, nonsurgical options. However, with the introduction of collagenase clostridium histolyticum to treat Dupuytren's contractures, physicians and surgeons may be provided with a new, office-based, non-surgical option to treat this disease.

    PubMedID: 20666587

Stanford Medicine Resources:

Footer Links: